Advancements in the Management of Gynecological Cancers: ESMO 2024 - Episode 9
Integrating Tisotumab Vedotin into Ovarian Cancer Therapy
Panelists discuss the integration of tisotumab vedotin into ovarian cancer therapy, covering its role in treatment approaches, patient selection, adverse event management, clinical pearls, challenges in practice, and the implications of the drug’s payload on treatment efficacy.
Video content above is prompted by the following:
- Where does tisotumab vedotin fit in your current treatment approach?
- In which patients do you consider this treatment option?
- Adverse event management and clinical pearls
- What challenges do you see in practice with tisotumab vedotin, and how do you approach associated management?
- Payload of tisotumab vedotin
Related Content:
